Análise crítica dos estudos que mudaram a prática clínica recente: diabetes mellitus e doenças cardiovasculares

Saraiva, José Francisco Kerr; Coutinho, Elaine dos Reis; Gonçalves, Mayara Pacheco.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 29(3): 246-248, jul.-set. 2019. tab
Artículo en Inglés, Portugués | LILACS | ID: biblio-1022942

Documentos relacionados

  1. Effects of SGLT2 inhibitors and GLP1-receptor agonists on cardiovascular and limb events in peripheral artery disease: A review.
  2. Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial.
  3. Canagliflozin impedes ischemic hind-limb recovery in the setting of diabetes.
  4. Fixed-Dose Combination of Canagliflozin and Metformin as an Adjunct to Diet and Exercise in Indian Adults with Type 2 Diabetes Mellitus: Results from a Multicentric, Open-Label, Single-Arm, Phase IV Study.
  5. Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial.
  6. [Study of gene expression in patients with peripheral artery disease].
  7. The interrelationship between diabetes mellitus and peripheral arterial disease.
  8. Daly/Cost comparison in the management of peripheral arterial disease at 17 Belgian hospitals.
  9. Exploring the Reporting Standards of Randomised Controlled Trials Involving Endovascular Interventions for Peripheral Arterial Disease: A Systematic Review.
  10. Diversity in randomized clinical trials for peripheral artery disease: a systematic review.